ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint744,816 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZugKalVista Pharmaceuticals Switzerland GmbH
KalVista Pharmaceuticals Switzerland GmbH Logo
Verified· 2 sources

KalVista Pharmaceuticals Switzerland GmbH

Summary

About the company

The purpose of the company is the discovery, development and marketing of pharmaceutical products. The company may acquire, manage and transfer intellectual property rights. The company may acquire, hold, manage and sell participations in companies of all kinds in Switzerland and abroad. The company may also conduct all business and enter into agreements that are suitable to serve the purpose of the company or the interests of its affiliated companies or that are directly or indirectly related thereto. The company may participate in other companies, acquire, establish or merge with companies. The company may grant loans and other financings to its direct and indirect parent companies and their direct and indirect subsidiary companies and provide securities of all kinds for liabilities of such companies, including by way of pledges on or fiduciary transfers of the company's assets or guarantees of any kind, whether against payment or not. The company may establish branches and subsidiaries in Switzerland and abroad, as well as acquire, encumber, hold, manage, rent and sell real estate.

Commercial register, canton of ZG·As of August 5, 2026View on Zefix
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered4
Development of medicines for hereditary angioedema (HAE)
Development of orally administered small-molecule medicines for hereditary angioedema, focused on new treatment options and the needs of HAE patients.
Research and pipeline development
Research, scientific development and pipeline work for medicines, starting with HAE and an oral Factor-XIIa inhibitor.
Information for patients and caregivers
Patient information on HAE, treatment options, and disease-related background information for patients and caregivers.
Information for healthcare professionals
Specialist information for healthcare professionals on HAE, scientific background and treatment-related content.

Knowledge

No knowledge articles yet

Once KalVista Pharmaceuticals Switzerland GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

KalVista Pharmaceuticals Switzerland GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank KalVista Pharmaceuticals Switzerland GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of KalVista Pharmaceuticals Switzerland GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Baarerstrasse 135
6300 Zug

At a glance

Legal form
Limited Liability Company
UID
CHE-476.260.624
Founded
2024 · 2 years
Last commercial register change
August 5, 2026
Employees
1 to 10

Similar companies

TP
Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug
Zug
AA
AKROSWISS AG
Zug
AP
Almeda Pharmaceuticals AG
Zug
BI
BridgeBio International GmbH
Zug
CA
Cellis AG
Zug
CH
Cilag Holding AG
Zug
BM
Biogen Management Services GmbH
Baar
MA
Maras AG
Cham